Anti-Mullerian hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles

References

• Andersen, C. Y., & Byskov, A. G. (2006). Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: Analysis of small antral and preovulatory human follicles’ fluid. The Journal of clinical endocrinology and metabolism, 91, 4064–4069.
   PubMed Web of Science ®Google Scholar
• Baczkowski, T., Kurzawa, R., & Glabowski, W. (2004). Methods of embryo scoring in in vitro fertilization. Reproductive biology, 4, 5–22.
   PubMedGoogle Scholar
• Bancsi, L. F., Broekmans, F. J., Looman, C. W., Habbema, J. D., & te Velde E. R. (2004a). Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertility and sterility, 81, 35–41.
   PubMed Web of Science ®Google Scholar
• Bancsi, L. F., Broekmans, F. J., Looman, C. W., Habbema, J. D., & te Velde E. R. (2004b). Predicting poor ovarian response in IVF: Use of repeat basal FSH measurement. The Journal of reproductive medicine, 49, 187–194.
   PubMed Web of Science ®Google Scholar
• Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. (2006). A systematic review of tests predicting ovarian reserve and IVF outcome. Human reproduction update, 12, 685–718.
   PubMed Web of Science ®Google Scholar
• Broekmans, F. J., de Ziegler, D., Howles, C. M., Gougeon, A., Trew, G., & Olivennes, F. (2010). The antral follicle count: Practical recommendations for better standardization. Fertility and sterility, 94, 1044–1051.
   PubMed Web of Science ®Google Scholar
• Broer, S. L., Mol, B. W., Hendriks, D., & Broekmans, F. J. (2009). The role of antimullerian hormone in prediction of outcome after IVF: Comparison with the antral follicle count. Fertility and sterility, 91, 705–714.
   PubMed Web of Science ®Google Scholar
• de Vet, A., Laven, J. S., de Jong, F. H., Themmen, A. P., & Fauser, B. C. (2002). Antimüllerian hormone serum levels: A putative marker for ovarian aging. Fertility and sterility, 77, 357–362.
   PubMed Web of Science ®Google Scholar
• Donahoe, P. K., Clarke, T., Teixeira, J., Maheswaran, S., & MacLaughlin, D. T. (2003). Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications. Molecular and cellular endocrinology, 211, 37–42.
   PubMed Web of Science ®Google Scholar
• Durlinger, A. L., Gruijters, M. J., Kramer, P., Karels, B., Ingraham, H. A., Nachtigal, M. W., et al. (2002). Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology, 143, 1076–1084.
   PubMed Web of Science ®Google Scholar
• Durlinger, A. L., Gruijters, M. J., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., et al. (2001). Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology, 142, 4891–4899.
   PubMed Web of Science ®Google Scholar
• Durmusoglu, F., Elter, K., Yoruk, P., & Erenus, M. (2004). Combining cycle day seven follicle count with the basal antral follicle count improves the prediction of ovarian response. Fertility and sterility, 81, 1073–1078.
   PubMed Web of Science ®Google Scholar
• Ebner, T., Sommergruber, M., Moser, M., Shebl, O., Schreier-Lechner, E., & Tews, G. (2006). Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Human reproduction (Oxford, England), 21, 2022–2026.
   PubMed Web of Science ®Google Scholar
• Eldar-Geva, T., Ben-Chetrit, A., Spitz, I. M., Rabinowitz, R., Markowitz, E., Mimoni, T., et al. (2005a). Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Human reproduction (Oxford, England), 20, 3178–3183.
   PubMed Web of Science ®Google Scholar
• Fanchin, R., Schonäuer, L. M., Righini, C., Guibourdenche, J., Frydman, R., & Taieb, J. (2003b). Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Human reproduction (Oxford, England), 18, 323–327.
   PubMed Web of Science ®Google Scholar
• Fanchin, R., Mendez Lozano, D. H., Frydman, N., Gougeon, A., di Clemente, N., Frydman, R., et al. (2007). Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. The Journal of clinical endocrinology and metabolism, 92, 1796–1802.
   PubMed Web of Science ®Google Scholar
• Fiçicioglu, C., Kutlu, T., Baglam, E., & Bakacak, Z. (2006). Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertility and sterility, 85, 592–596.
   PubMed Web of Science ®Google Scholar
• Frattarelli, J. L., Levi, A. J., Miller, B. T., & Segars, J. H. (2003). A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertility and sterility, 80, 350–355.
   PubMed Web of Science ®Google Scholar
• Hansen, K. R., Morris, J. L., Thyer, A. C., & Soules, M. R. (2003). Reproductive aging and variability in the ovarian antral follicle count: Application in the clinical setting. Fertility and sterility, 80, 577–583.
   PubMed Web of Science ®Google Scholar
• Hehenkamp, W. J., Looman, C. W., Themmen, A. P., de Jong, F. H., Te Velde, E. R., & Broekmans, F. J. (2006). Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. The Journal of clinical endocrinology and metabolism, 91, 4057–4063.
   PubMed Web of Science ®Google Scholar
• Josso, N., Cate, R. L., Picard, J. Y., Vigier, B., di Clemente, N., Wilson, C., et al. (1993). Anti-müllerian hormone: The jost factor. Recent progress in hormone research, 48, 1–59.
   PubMedGoogle Scholar
• Kevenaar, M. E., Themmen, A. P., Laven, J. S., Sonntag, B., Fong, S. L., Uitterlinden, A. G., et al. (2007). Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Human reproduction (Oxford, England), 22, 1547–1554.
   PubMed Web of Science ®Google Scholar
• Kwee, J., Schats, R., McDonnell, J., Themmen, A., de Jong, F., & Lambalk, C. (2008). Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertility and sterility, 90, 737–743.
   PubMed Web of Science ®Google Scholar
• La Marca, A., Broekmans, F. J., Volpe, A., Fauser, B. C., & Macklon, N. S.; ESHRE Special Interest Group for Reproductive Endocrinology–AMH Round Table. (2009). Anti-Mullerian hormone (AMH): What do we still need to know? Human reproduction (Oxford, England), 24, 2264–2275.
   PubMed Web of Science ®Google Scholar
• La Marca, A., De Leo, V., Giulini, S., Orvieto, R., Malmusi, S., Giannella, L., et al. (2005b). Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. Journal of the Society for Gynecologic Investigation, 12, 545–548.
   PubMedGoogle Scholar
• La Marca, A., Giulini, S., Tirelli, A., Bertucci, E., Marsella, T., Xella, S., et al. (2007). Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Human reproduction (Oxford, England), 22, 766–771.
   PubMed Web of Science ®Google Scholar
• La Marca, A., Stabile, G., Artenisio, A. C., & Volpe, A. (2006b). Serum anti-Mullerian hormone throughout the human menstrual cycle. Human reproduction (Oxford, England), 21, 3103–3107.
   PubMed Web of Science ®Google Scholar
• Lee, M. M., Donahoe, P. K., Hasegawa, T., Silverman, B., Crist, G. B., Best, S., et al. (1996). Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood. The Journal of clinical endocrinology and metabolism, 81, 571–576.
   PubMed Web of Science ®Google Scholar
• Lee, M. M., & Donahoe, P. K. (1993). Mullerian inhibiting substance: A gonadal hormone with multiple functions. Endocrine reviews, 14, 152–164.
   PubMed Web of Science ®Google Scholar
• Lee, T. H., Liu, C. H., Huang, C. C., Wu, Y. L., Shih, Y. T., Ho, H. N., et al. (2008). Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Human reproduction (Oxford, England), 23, 160–167.
   PubMed Web of Science ®Google Scholar
• Maheshwari, A., Fowler, P., & Bhattacharya, S. (2006). Assessment of ovarian reserve–should we perform tests of ovarian reserve routinely? Human reproduction (Oxford, England), 21, 2729–2735.
   PubMed Web of Science ®Google Scholar
• Nakhuda, G. S., Chu, M. C., Wang, J. G., Sauer, M. V., & Lobo, R. A. (2006). Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization. Fertility and sterility, 85, 1541–1543.
   PubMed Web of Science ®Google Scholar
• Nelson, S. M., Yates, R. W., & Fleming, R. (2007). Serum anti-Müllerian hormone and FSH: Prediction of live birth and extremes of response in stimulated cycles–implications for individualization of therapy. Human reproduction (Oxford, England), 22, 2414–2421.
   PubMed Web of Science ®Google Scholar
• Peñarrubia, J., Fábregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., et al. (2005). Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist–gonadotropin treatment. Human reproduction (Oxford, England), 20, 915–922.
   PubMed Web of Science ®Google Scholar
• Scott, R. T., Jr, Hofmann, G. E., Oehninger, S., & Muasher, S. J. (1990). Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertility and sterility, 54, 297–302.
   PubMed Web of Science ®Google Scholar
• Seifer, D. B., & Maclaughlin, D. T. (2007). Mullerian Inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertility and sterility, 88, 539–546.
   PubMed Web of Science ®Google Scholar
• Smeenk, J. M., Sweep, F. C., Zielhuis, G. A., Kremer, J. A., Thomas, C. M., & Braat, D. D. (2007). Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertility and sterility, 87, 223–226.
   PubMed Web of Science ®Google Scholar
• Streuli, I., Fraisse, T., Pillet, C., Ibecheole, V., Bischof, P., & de Ziegler, D. (2008). Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertility and sterility, 90, 395–400.
   PubMed Web of Science ®Google Scholar
• Tremellen, K. P., Kolo, M., Gilmore, A., & Lekamge, D. N. (2005). Anti-mullerian hormone as a marker of ovarian reserve. The Australian & New Zealand journal of obstetrics & gynaecology, 45, 20–24.
   PubMed Web of Science ®Google Scholar
• Tsepelidis, S., Devreker, F., Demeestere, I., Flahaut, A., Gervy, C. h., & Englert, Y. (2007). Stable serum levels of anti-Müllerian hormone during the menstrual cycle: A prospective study in normo-ovulatory women. Human reproduction (Oxford, England), 22, 1837–1840.
   PubMed Web of Science ®Google Scholar
• van Rooij, I. A., Broekmans, F. J., te Velde, E. R., Fauser, B. C., Bancsi, L. F., de Jong, F. H., et al. (2002). Serum anti-Müllerian hormone levels: A novel measure of ovarian reserve. Human reproduction (Oxford, England), 17, 3065–3071.
   PubMed Web of Science ®Google Scholar
• van Rooij, I. A., Tonkelaar, I., Broekmans, F. J., Looman, C. W., Scheffer, G. J., de Jong, F. H., et al. (2004). Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause (New York, N.Y.), 11(6 Pt 1), 601–606.
   PubMedGoogle Scholar
• Visser, J. A., Durlinger, A. L., Peters, I. J., van den Heuvel, E. R., Rose, U. M., Kramer, P., et al. (2007). Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice. Endocrinology, 148, 2301–2308.
   PubMed Web of Science ®Google Scholar